Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects

Clinical trial NCT00805090 · COMPLETED

Trial details

NCT number: NCT00805090
Sponsor: Javelin Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Insufficiency, Chronic Hepatic Insufficiency Healthy

Start date: 2008-12-01
Primary completion: 2009-03-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.